Jonathan Stuart Kaplan

Array ( [id] => 33955 [patent_doc_number] => 07786264 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-31 [patent_title] => 'Monoclonal antibody against hepatitis E virus or its fragment with binding activity and use thereof' [patent_app_type] => utility [patent_app_number] => 10/495091 [patent_app_country] => US [patent_app_date] => 2002-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 29 [patent_no_of_words] => 36209 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/786/07786264.pdf [firstpage_image] =>[orig_patent_app_number] => 10495091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 411110 [patent_doc_number] => 07282205 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-16 [patent_title] => 'Anti-hepatitis A virus antibodies' [patent_app_type] => utility [patent_app_number] => 10/494676 [patent_app_country] => US [patent_app_date] => 2002-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18206 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/282/07282205.pdf [firstpage_image] =>[orig_patent_app_number] => 10494676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 366818 [patent_doc_number] => 07479547 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-20 [patent_title] => 'HIV-1 subtype isolate regulatory/accessory genes, and modifications and derivatives thereof' [patent_app_type] => utility [patent_app_number] => 10/494131 [patent_app_country] => US [patent_app_date] => 2002-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 38 [patent_no_of_words] => 9060 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/479/07479547.pdf [firstpage_image] =>[orig_patent_app_number] => 10494131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7208848 [patent_doc_number] => 20050053625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Method of treating viral infections' [patent_app_type] => utility [patent_app_number] => 10/494377 [patent_app_country] => US [patent_app_date] => 2002-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 24705 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20050053625.pdf [firstpage_image] =>[orig_patent_app_number] => 10494377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7423084 [patent_doc_number] => 20040265306 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Efficient inhibition of hiv-1 viral entry through a novel fusion protein including of cd4' [patent_app_type] => new [patent_app_number] => 10/493676 [patent_app_country] => US [patent_app_date] => 2004-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 23785 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20040265306.pdf [firstpage_image] =>[orig_patent_app_number] => 10493676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6663656 [patent_doc_number] => 20030202982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-30 [patent_title] => 'Influenza immunogen and vaccine' [patent_app_type] => new [patent_app_number] => 10/274616 [patent_app_country] => US [patent_app_date] => 2002-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 25858 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 433 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20030202982.pdf [firstpage_image] =>[orig_patent_app_number] => 10274616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6851324 [patent_doc_number] => 20030143527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Identification of oligonucleotides for the capture, detection and quantitation of hepatitis B viral DNA' [patent_app_type] => new [patent_app_number] => 10/267922 [patent_app_country] => US [patent_app_date] => 2002-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12695 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20030143527.pdf [firstpage_image] =>[orig_patent_app_number] => 10267922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 445667 [patent_doc_number] => 07252984 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-07 [patent_title] => 'Attenuated mutant newcastle disease virus strains for in ovo vaccination, method for preparing and their use' [patent_app_type] => utility [patent_app_number] => 10/491375 [patent_app_country] => US [patent_app_date] => 2002-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9949 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/252/07252984.pdf [firstpage_image] =>[orig_patent_app_number] => 10491375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6760735 [patent_doc_number] => 20030124096 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Viral variants and methods for detecting same' [patent_app_type] => new [patent_app_number] => 10/260451 [patent_app_country] => US [patent_app_date] => 2002-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7768 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20030124096.pdf [firstpage_image] =>[orig_patent_app_number] => 10260451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 893998 [patent_doc_number] => 07341723 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-11 [patent_title] => 'Nucleic acid construct encoding a processing component derived from the N-terminal region of the hepatitis virus ORF2, and an antigenic polypeptide' [patent_app_type] => utility [patent_app_number] => 10/260846 [patent_app_country] => US [patent_app_date] => 2002-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9631 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/341/07341723.pdf [firstpage_image] =>[orig_patent_app_number] => 10260846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7105780 [patent_doc_number] => 20050107587 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Hdv nucleic acid molecules fragments and applications thereof' [patent_app_type] => utility [patent_app_number] => 10/489864 [patent_app_country] => US [patent_app_date] => 2002-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13190 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20050107587.pdf [firstpage_image] =>[orig_patent_app_number] => 10489864 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 463129 [patent_doc_number] => 07238526 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-03 [patent_title] => 'Methods and cell line useful for production of recombinant adeno-associated viruses' [patent_app_type] => utility [patent_app_number] => 10/241024 [patent_app_country] => US [patent_app_date] => 2002-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 11668 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/238/07238526.pdf [firstpage_image] =>[orig_patent_app_number] => 10241024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6906135 [patent_doc_number] => 20050101530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Cellular virus receptors and methods of use' [patent_app_type] => utility [patent_app_number] => 10/486471 [patent_app_country] => US [patent_app_date] => 2002-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16035 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20050101530.pdf [firstpage_image] =>[orig_patent_app_number] => 10486471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6817849 [patent_doc_number] => 20030068807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Precursor conversion screening methods' [patent_app_type] => new [patent_app_number] => 10/210792 [patent_app_country] => US [patent_app_date] => 2002-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6955 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20030068807.pdf [firstpage_image] =>[orig_patent_app_number] => 10210792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7210600 [patent_doc_number] => 20050053914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Hepatitis b virus pre-s1 derived synthetic polypeptides and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/484923 [patent_app_country] => US [patent_app_date] => 2002-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5513 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20050053914.pdf [firstpage_image] =>[orig_patent_app_number] => 10484923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6715940 [patent_doc_number] => 20030027288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => 'Methods of screening for agents that inhibit aggregation of polypeptides' [patent_app_type] => new [patent_app_number] => 10/194584 [patent_app_country] => US [patent_app_date] => 2002-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9158 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20030027288.pdf [firstpage_image] =>[orig_patent_app_number] => 10194584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6829226 [patent_doc_number] => 20030180284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Prevention and treatment of HCV infection employing antibodies directed against conformational and linear epitopes' [patent_app_type] => new [patent_app_number] => 10/188608 [patent_app_country] => US [patent_app_date] => 2002-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 37454 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20030180284.pdf [firstpage_image] =>[orig_patent_app_number] => 10188608 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4504741 [patent_doc_number] => 07914800 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-29 [patent_title] => 'LTB4 as vaccine adjuvant' [patent_app_type] => utility [patent_app_number] => 10/482393 [patent_app_country] => US [patent_app_date] => 2002-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5098 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/914/07914800.pdf [firstpage_image] =>[orig_patent_app_number] => 10482393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4538289 [patent_doc_number] => 07875422 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-25 [patent_title] => 'Viral drug susceptibility testing' [patent_app_type] => utility [patent_app_number] => 10/479511 [patent_app_country] => US [patent_app_date] => 2002-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6164 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/875/07875422.pdf [firstpage_image] =>[orig_patent_app_number] => 10479511 [rel_patent_id] =>[rel_patent_doc_number] =>)